Redwood Wealth Management Group, LLC Recursion Pharmaceuticals, Inc. Transaction History
Redwood Wealth Management Group, LLC
- $133 Billion
- Q2 2024
A detailed history of Redwood Wealth Management Group, LLC transactions in Recursion Pharmaceuticals, Inc. stock. As of the latest transaction made, Redwood Wealth Management Group, LLC holds 2,500 shares of RXRX stock, worth $16,900. This represents 0.01% of its overall portfolio holdings.
Number of Shares
2,500Holding current value
$16,900% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding RXRX
# of Institutions
285Shares Held
236MCall Options Held
972KPut Options Held
2.4M-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl28.1MShares$190 Million1.92% of portfolio
-
Baillie Gifford & CO26.6MShares$180 Million0.16% of portfolio
-
Vanguard Group Inc Valley Forge, PA21.6MShares$146 Million0.0% of portfolio
-
Black Rock Inc. New York, NY17.3MShares$117 Million0.0% of portfolio
-
Ra Capital Management, L.P. Boston, MA15.4MShares$104 Million1.74% of portfolio
About RECURSION PHARMACEUTICALS, INC.
- Ticker RXRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 180,480,000
- Market Cap $1.22B
- Description
- Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase IIa clinical trial to treat cerebral cav...